Advertisement

Drugs & Therapy Perspectives

, Volume 34, Issue 8, pp 404–404 | Cite as

Correction to: Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use

  • Katherine A. Lyseng-Williamson
Open Access
Correction
  • 1.4k Downloads

Correction to: Drugs Ther Perspect 2018;34(1):8–15  https://doi.org/10.1007/s40267-017-0459-x

The article Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use, written by Katherine A. Lyseng-Williamson, was originally published Online First without open access. After publication in volume 34, issue 1, pages 8–15, F. Hoffmann-La Roche AG requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by F. Hoffmann-La Roche AG. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The ​original ​article ​has ​been ​corrected.

Copyright information

© Springer Nature 2018

Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations